Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
P2Y2 and Gq/G11 control blood pressure by mediating endothelial mechanotransduction
ShengPeng Wang, … , Nina Wettschureck, Stefan Offermanns
ShengPeng Wang, … , Nina Wettschureck, Stefan Offermanns
Published July 13, 2015
Citation Information: J Clin Invest. 2015;125(8):3077-3086. https://doi.org/10.1172/JCI81067.
View: Text | PDF
Research Article Vascular biology

P2Y2 and Gq/G11 control blood pressure by mediating endothelial mechanotransduction

  • Text
  • PDF
Abstract

Elevated blood pressure is a key risk factor for developing cardiovascular diseases. Blood pressure is largely determined by vasodilatory mediators, such as nitric oxide (NO), that are released from the endothelium in response to fluid shear stress exerted by the flowing blood. Previous work has identified several mechanotransduction signaling processes that are involved in fluid shear stress–induced endothelial effects, but how fluid shear stress initiates the response is poorly understood. Here, we evaluated human and bovine endothelial cells and found that the purinergic receptor P2Y2 and the G proteins Gq/G11 mediate fluid shear stress–induced endothelial responses, including [Ca2+]i transients, activation of the endothelial NO synthase (eNOS), phosphorylation of PECAM-1 and VEGFR-2, as well as activation of SRC and AKT. In response to fluid shear stress, endothelial cells released ATP, which activates the purinergic P2Y2 receptor. Mice with induced endothelium-specific P2Y2 or Gq/G11 deficiency lacked flow-induced vasodilation and developed hypertension that was accompanied by reduced eNOS activation. Together, our data identify P2Y2 and Gq/G11 as a critical endothelial mechanosignaling pathway that is upstream of previously described mechanotransduction processes and demonstrate that P2Y2 and Gq/G11 are required for basal endothelial NO formation, vascular tone, and blood pressure.

Authors

ShengPeng Wang, András Iring, Boris Strilic, Julián Albarrán Juárez, Harmandeep Kaur, Kerstin Troidl, Sarah Tonack, Joachim C. Burbiel, Christa E. Müller, Ingrid Fleming, Jon O. Lundberg, Nina Wettschureck, Stefan Offermanns

×

Figure 2

Endothelial Gαq and Gα11 are required for flow-induced vasodilation.

Options: View larger image (or click on image) Download as PowerPoint
Endothelial Gαq and Gα11 are required for flow-induced vasodilation.
(A ...
(A and B) Mesenteric arteries from tamoxifen-treated WT or EC-q/11–KO mice were exposed to flow and various agents. (A) Effect of a stepwise increase in perfusion flow on the diameter of vessels precontracted with 100 nM of the thromboxane A2 analog U46619. After flow was stopped, 10 μM ACh and 100 μM SNP were added. Shown is the evaluation of the AUC and the time course of flow-induced vasorelaxation as a percentage of the passive vessel diameter (n = 6, WT; n = 8, EC-q/11–KO). (B) Effect of ACh, SNP, and phenylephrine on vascular diameter (n = 6). Data represent the mean ± SEM; **P ≤ 0.01 and ***P ≤ 0.001, by 2-tailed Student’s t test (A, middle) and 2-way ANOVA, with Bonferroni’s post-hoc test (A, right and B).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts